Company / Working Capital
TherapeuticsMD, Inc. Working Capital History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$7.1M
FY2024
5-year range
-$133.4M / $69.2M
FY2020-FY2024
Trend
+43.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 10 years, ranging from -$133M in FY2021 to $155M in FY2019.
Based on SEC 10-K filings.
$7M in FY2024 with a 5-year CAGR of -46.1%.
Declined from $9M to $7M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -46.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -46.1%, indicating a declining trend.
- In FY2024, working capital increased 43.5% year-over-year.
- Peak working capital was recorded in FY2019.
- Lowest working capital in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $7.1M | +43.5% |
| FY2023 | $4.9M | -41.9% |
| FY2022 | $8.5M | +106.4% |
| FY2021 | -$133.4M | -292.9% |
| FY2020 | $69.2M | -55.5% |
| FY2019 | $155.4M | +6.7% |
| FY2018 | $145.7M | +15.4% |
| FY2017 | $126.2M | +1.5% |
| FY2016 | $124.4M | +107.3% |
| FY2015 | $60.0M | +31.8% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026